breast cancer and semaglutide is Associated with Improved Survival, Lower Metastatic Burden, a Dose–Survival Relationship Uncoupled from Weight-Loss Magnitude[v1] GLP-1s appear to cut cancer
Pay in 4 interest-free payments of $6.28 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
![breast cancer and semaglutide is Associated with Improved Survival, Lower Metastatic Burden, a DoseSurvival Relationship Uncoupled from Weight-Loss Magnitude[v1] GLP-1s appear to cut cancer](https://npr.brightspotcdn.com/dims3/default/strip/false/crop/5400x3038+0+209/resize/1400/quality/85/format/jpeg/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2F32%2F86%2F765aa4704e13aac27deda3103de6%2Fgettyimages-2279484839.jpg)
![breast cancer and semaglutide is Associated with Improved Survival, Lower Metastatic Burden, a DoseSurvival Relationship Uncoupled from Weight-Loss Magnitude[v1] GLP-1s appear to cut cancer](https://www.sciencealert.com/images/2026/06/BreastCancer.jpg)
![breast cancer and semaglutide is Associated with Improved Survival, Lower Metastatic Burden, a DoseSurvival Relationship Uncoupled from Weight-Loss Magnitude[v1] GLP-1s appear to cut cancer](https://www.mdpi.com/ijms/ijms-26-07744/article_deploy/html/images/ijms-26-07744-g001.png)



.jpeg)

















